Introduction
Osteopenia and osteoporosis are conditions of metabolic bone disorders. According to the World Health Organization (WHO), osteoporosis in post-menopausal women is deyoung adult mean 1 , and osteopenia, or low bone density, is conditions are known as primary osteoporosis as they occur among the elderly and post-menopausal women 2,3 . The risk of osteoporosis and osteopenia increases as people age. correlated with advancing age 4 .This silent disease is alarmsymptom is evident before the occurrence of fracture. Fragility fracture is a nightmare to all post-menopausal women because it leads to serious complications and even death.
Approximately one in every three women over the age of 50 years will encounter a fragility fracture throughout her life 5 . About 61% of fragility fractures occurs in women, with female to male ratio of 1.6 6 above the age of 60 between June 2008 and December 2009 these women were post-menopausal at the time of the fracture 7 . The high incidence of osteoporotic fractures among and mortality 8 . Therefore, proper prevention and treatment cant developments have occurred in the pharmacotherapy risk of fractures. These developments have substantially improved the management of patients with osteoporosis. Unfortunately, the risk of fragility fractures is not yet eliminated because there are still unmet needs requiring a broader range of therapeutic 9 and preventive steps.
The prediction of fracture risk is one of the valuable tools in calculating the 10-year probability of obtaining a major fracture and hip fracture 10 . The incidence of fragility fracture as a major cause of disability, poor quality of life and mortality can be reduced by the proper assessment of fracture risk. FRAX score is a new fracture risk assessment tool (FRAX ® ) that is widely used in determining a 10-year prediction for possible fractures, and it is recommended by the and bone mineral density measured by dual-energy X-ray absorptiometry 11 . Aside from providing a 10-year probability of obtaining fracture, this tool can assist in identifying those who are at the greatest risk of fracture, which can be detected early to aid in planning immediate preventive measures. At the same time, it can support clinical decision making in fracture risk management to reduce fracture-related disability, costs, and mortality. This study aims to identify the fracture risk prediction in post-menopausal women with osteopenia and osteoporosis. We present the ment of health education package in preventing fracture
Method
This study applied a cross-sectional method involving 87 respondents from the orthopedic and menopause clinics of between April 2016 and October 2016. A purposive sample of the respondents' age of 50 and above and post-menopausal women was utilized. The criteria in selecting respon-lection was performed after obtaining approval from the Research Ethics Committee of the International Islamic Uni-dents were evaluated using a questionnaire on various independent risk factors for osteoporosis, including parental hip fractures, previous fractures, current cigarette smoking habit, glucocorticosteroid usage, alcohol consumption, rheumatoid arthritis, caffeinated drinks, and years of menopause. Physical examinations included weight and -The WHO fracture risk assessment tool (FRAX ® ) was used to calculate the risk for major and hip fracture probability in 10 years' time. The selection of an appropriate country for the FRAX tool was conducted because no FRAX tool was FRAX ® chosen based on the likelihood that it is a representative of the index country in terms of life expectancy and fracture incidence 10 . Therefore, the calculation for Singapore was chosen because the population comprised of three major -® is a computer-based algorithm 12 . Descriptive data were generated for all the variables. The Pearson correlation test was conducted to determine the relationship between the independent variables and the FRAX 10-year probability of fracture. Correlation was and analysis were performed using SPSS version 20.0 (2011).
Results
Out of the 87 post-menopausal women recruited, 50.6% were osteopenic and nearly half (48.3%) had osteoporosis (Figure 1) . The mean age of the respondents was 61.6 years 42.9% 2.9%
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